Durvalumab-induced thyroiditis in a patient with non-small cell lung carcinoma: a case report and review of pathogenic mechanisms

BACKGROUND: Immune checkpoint inhibitors (ICI) targeting cytotoxic T-lymphocyte-associated protein 4 (CTLA-4), programmed cell death protein 1 and its ligand (PD-1/PD-L1) have become the current standard-of-care for advanced cancers. This novel therapeutic approach comes with its costs in the form o...

Descripción completa

Detalles Bibliográficos
Autores principales: de Filette, Jeroen M. K., André, Stéphanie, De Mey, Lynn, Aspeslagh, Sandrine, Karmali, Rafik, Van der Auwera, Bart J, Bravenboer, Bert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682778/
https://www.ncbi.nlm.nih.gov/pubmed/36419114
http://dx.doi.org/10.1186/s12902-022-01190-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9682778/
https://www.ncbi.nlm.nih.gov/pubmed/36419114
http://dx.doi.org/10.1186/s12902-022-01190-5

Ejemplares similares